The content on this page is marketing communication
Equity funds h4>
SKAGEN Vekst B
Annual cost up to
| Platform fee up to | 0.00% |
| Ongoing charges | 0.80% |
| Of which management fee | 0.80% |
| Kickback | -0.00% |
| Total annual cost up to | 0.80% |
* Returns beyond 12 months are annualised average returns, calculated after costs.
** The price of the fund affects its future return. The fund is charged an ongoing annual cost as shown above. For example, an investment of NOK 100,000 in this fund with 0% return would result in an annual cost of up to NOK 800.
SKAGEN Vekst
SKAGEN Vekst invests in companies that are attractively priced relative to expected profitability and growth. The majority of the fund is invested in the Nordic region and the remainder worldwide. The fund's objective is to provide unit holders with the best possible return for the risk taken by the fund. The fund is suitable for investors with a minimum five-year investment horizon.
Subscriptions are made in fund units and not directly in stocks or other securities. The benchmark reflects the fund's investment mandate. Since the fund is actively managed, the portfolio will deviate from the composition of the benchmark.
Historical performance
| Period |
|---|
Last updated:
Effective 1/1/2014, the Fund's investment mandate changed from investing a minimum of 50% of its funds in Norway to investing a minimum of 50% of its funds in the Nordic countries. This means that returns prior to the change were achieved under different circumstances than they are today.
The current benchmark index is MSCI Nordic/MSCI AC ex. Nordic. Prior to 1/1/2014, the benchmark index was an evenly composed benchmark index consisting of the Oslo Stock Exchange Benchmark Index (OSEBX) and the MSCI All Country World. The benchmark index prior to 1/1/2010 was the Oslo Stock Exchange Benchmark Index (OSEBX). Returns over 12 months are annualised.
Portfolio Managers
Søren Milo Christensen
SKAGEN Vekst
Sondre Solvoll Bakketun
SKAGEN Vekst
Top ten investments
as of 30/04/2026 - 32.99 % of all investments
Novo Nordisk A/S
4.60 %
Hana Financial Group Inc
3.94 %
Ping An Insurance Group Co of China Ltd
3.43 %
ISS A/S
3.25 %
Nordea Bank Abp
3.21 %
3.21 %
Bakkafrost P/F
3.02 %
2.81 %
DSV A/S
2.76 %
CK Asset Holdings Ltd
2.76 %